General Information
DRAVP ID DRAVPs019
Peptide Name NYBSP-4
Sequence TIEEQⓏKTFLDKⓍNHEAEDLFYQⓍSLAⓍWN
Sequence Length 30
Original Sequence TIEEQKTFLDKNHEAEDLFYQSLAWN
Source Synthetic Construct
Validation Experimentally Validated
Activity Information
Target Organism SARS-CoV-2
Assay Inhibition assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target membrane
Mechanism Proteolytic stability of NYBSP-4 in human plasma(half-life (T1/2) of NYBSP-4 was >289 min).The stapled peptide designed based on the ACE2 helix, which is expected to bind to SARS-CoV-2 and prevent the binding of the virus to the ACE2 receptor and disrupt the infection.
Structure Information
Linear/Cyclic Cyclic
N-terminal Modification Acetylation
C-terminal Modification Amidation
Special Amino Acid and Stapling Position ①The Ⓧ (position: 13,24 and 28) in sequence indicate S-2-(4'-pentenyl) alanine.②The Ⓩ (position: 6) indicates 2-(7'-octenyl) alanine in the R configuration.③ Ⓩ(6) and Ⓧ(13), Ⓧ(24) and Ⓧ(28) are cross-linked by hydrocarbon stapling.
Structure Description 80% α-helical content in 10 mM phosphate-buffered saline (PBS)
Stereochemistry L
Literature Information
Literature 1
Title Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro.
Pubmed ID 33310780
Reference mBio. 2020 Dec 11;11(6):e02451-20.
Author Curreli F, Victor SMB, Ahmed S, Drelich A, Tong X, Tseng CK, Hillyer CD, Debnath AK.
DOI 10.1002/psc.3409